Join ACCP

 
Grants & Funding Opportunities

As part of ACCP's ongoing commitment to Members, we will routinely post appropriately aligned Grants & Funding Opportunities from a variety of sources. Information will be updated in a timely manner and we encourage Members to visit this link frequently for up-to-date information on valuable funding sources. Members are welcome to recommend additional links for posting by forwarding the information to Info@ACCP1.org. Angelman Syndrome Foundation Announces $1 Million RFP for AS Research

POSTED: July 26, 2014
DEADLINE: October 15, 2014

The Angelman Syndrome Foundation's mission is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with AS, their families, and other concerned parties. To date, the foundation has invested more than $6 million in AS research, supporting seventy-eight projects worldwide.

ASF has issued a $1 million Request for Proposals for new AS-related research projects. One- or two-year grants of up to $100,000 per year will be awarded to promising preclinical, translational, or clinical research projects that investigate any aspect of AS. Priority will be given to pilot projects to test new ideas about AS pathogenesis and therapeutics.

AACR Invites Letters of Intent for Basic Cancer Research Fellowships

POSTED: September 27, 2014
DEADLINE: October 28, 2014 (Letters of Intent)

The American Association for Cancer Research is accepting Letters of Intent for its Basic Cancer Research Fellowship program.

The program, which is open to postdoctoral and clinical research fellows who are working at an academic, medical, or research institution and will be in the first, second, or third year of their postdoctoral training at the start of the grant term (July 1, 2015), provides one-year grants of $50,000 to help cover salary and benefit costs of fellows working on a mentored basic cancer research project. A portion of the funds may be designated for non-personnel expenses such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

To be eligible, applicants must have a doctoral degree (Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent degree) in a related field and not currently be a candidate for a further terminal degree. In addition, AACR membership is required. Non-members interested in this grant opportunity must submit a satisfactory application for AACR Associate Membership by October 28, 2014. Full applications from those invited to apply based on their Letter of Intent will be due February 10, 2015.

Michael J. Fox Foundation for Parkinson's Research Invites Proposals for Target Pipeline Program

POSTED: July 6, 2014
DEADLINE: October 29, 2014 (Pre-proposals)

The Michael J. Fox Foundation for Parkinson's Research, which seeks to stimulate development of Parkinson's disease therapeutics, is accepting pre-proposals for the spring cycle of its Target Validation program.

Part of the foundation’s annual Edmond J. Safra Core Programs for PD Research, the Target Validation program supports work seeking to determine whether manipulating a novel biological target has impact in a Parkinson’s disease-relevant animal model -- an essential early step to the development of potentially promising therapies.

The program supports two-year grants of up to $250,000. Total annual direct costs cannot exceed $100,000, and no more than 2 percent (academic institutions) or 10 percent (for-profit organizations) may go to indirect costs.

Milstein Medical Asian American Partnership Invites Applications for Fellowships in Translational Medicine

POSTED: September 18, 2014
DEADLINE: November 1, 2014

The mission of the Milstein Medical Asian American Partnership Foundation is to improve world health by developing mutually beneficial partnerships between the United States and China and the U.S. and the countries of greater Asia.

To that end, the foundation is inviting applications from mainland China for its Fellowship Award in Translational Research. The aim of the program is to build enduring partnership between the U.S. and Asia through the training of future Chinese academics and to encourage long-term collaborations between the two regions.

The annual award provides a one-year fellowship to a qualified candidate to conduct research in the area of translational medicine. The program will provide support in the amount of $60,000 for the project to be conducted at the applicant’s home institution in China, as well as support for the U.S. partner institution in the amount of $25,000.

To be eligible, applicants must have a career goal to be a distinguished researcher focused on the challenges of translational medicine and come from a major medical center with demonstrated excellence in translational medicine. In addition, applicants must possess an M.D. or Ph.D. in any specialty or medical subspecialties; significant research experience and a distinguished publication record; commitment to research and academics; demonstrated leadership skills; and excellent English-speaking proficiency.

Alex's Lemonade Stand Foundation Accepting Letters of Intent for Innovation Grants

POSTED: September 27, 2014
DEADLINE: November 3, 2014

Alex's Lemonade Stand Foundation, a nonprofit foundation that has evolved from a young cancer patient's front-yard lemonade stand to a national foundation for childhood cancer, awards grants aimed at filling critical voids in current pediatric cancer research.

Through its Innovation Grants program, the foundation awards two-year grants of up to $250,000 to researchers with a novel approach to pediatric oncology scientific investigation. This may represent a change in research direction and/or a new idea that moves away from an investigator’s prior research but has the potential to advance research on childhood cancers. Innovation Grants will support research carried out by investigators who are already established, have a track record of peer-reviewed publications, and can provide evidence of successfully competing for extramural funding.

To be eligible, applicants must possess a degree at the at the M.D., M.D./Ph.D, or Ph.D. level and hold a faculty appointment at an academic institution in the United States or Canada.

AACR Issues RFP for Lung Cancer Translational Research Dream Team Grant

POSTED: October 1, 2014
DEADLINE: November 5, 2014 (Letters of Intent)

The American Association for Cancer Research, in partnership with the American Cancer Society and Stand Up to Cancer, has issued a Request for Proposals for the Stand Up to Cancer-American Cancer Society Lung Cancer Translational Research Dream Team Grant.

The initiative aims to advance lung cancer research through the creation of a collaborative, translational, research "Dream Team" featuring talented and promising researchers with the expertise needed to solve key problems in lung cancer. The team will span multiple disciplines and institutions and will utilize the new tools of modern biology to attack research questions in a coordinated way.

To that end, AACR will award up to $20 million over three years in support of a translational cancer research project that addresses critical problems in lung cancer and positively impacts patients in the near future. The project should include new immunological approaches to and therapeutic interventions for lung cancer and have the potential to deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional team of expert investigators.

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant (R01)

The application due dates are February 4, 2015; February 3, 2016; February 1, 2017; and February 7, 2018

The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of FDA's Office of Orphan Products Development grant program. The goal of FDA's Orphan Products Development (OPD) grant program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the application's Background and Significance section documentation to support the assertion that the product to be studied meets the statutory criteria to qualify for the grant and an explanation of how the proposed study will either help support product approval or provide essential data needed for product development.

Grant funding opportunities at the National Institutes of Health can be found at http://grants.nih.gov/grants/guide/. To Subscribe to the NIH Guide LISTSERV, send an e-mail to listserv@list.nih.gov with the following text in the message body (not the "Subject" line):
subscribe NIHTOC-L your name
(Example: subscribe NIHTOC-L Bill Jones)

Your e-mail address will be automatically obtained from the e-mail message and add you to the LISTSERV.

Grant opportunities from the Substance Abuse and Mental Health Administration:
http://www.samhsa.gov/samhsa_news/volumexvi_1/article5.htm

www.Grants.gov provides information on funding opportunities across all US Federal agencies:

Grant opportunities from the Alzheimer's Drug Discovery Foundation:
http://www.alzdiscovery.org/index.php/research-programs/grant-opportunities

CenterWatch offers several easy-to-search resources on drugs in various stages of development and approval:
http://www.centerwatch.com/drug-information/



21750 Red Rum Drive, Suite 137, Ashburn, VA  20147    Mailing address: PO Box 1758, Ashburn, VA  20146
571-291-3493     Fax: 571-918-4167     Contact Us
Home     About ACCP     Member Login     Healthcare Professionals
Continuing Education     Meetings     Publications     Public Policy     Student Outreach

Site Map | Site contents © 2014 ACCP